This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 269,00 per year only 22,42 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
By addressing these factors, patients may experience a holistic improvement in their overall health profile
In comparison, lanifibranor, a pan-peroxisome proliferator-activated receptor (PPAR-//) agonist, achieved significant benefits on both NASH and fibrosis histology in a recent clinical phase 2b study (NATIVE trial) 26
doi: 10.1177/000348949510400205
A lab visit with their favourite alcohol was repeated at the end of the study
some patients achieve excellent results with minimal side effects, while persistent or severe symptoms may indicate a need for dose adjustment
